Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
J-Pharma CoTSE:520A -2.36%9 Market Cap is 円5,215.55 Mil as of Jul. 14, 2026. GuruFocus rates TSE:520A with a GF Score™ of 9/100. Among 1,423 Biotechnology companies, J-Pharma Co ranks worse than 69.99% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). J-Pharma Co's share price for the quarter that ended in Dec. 2025 was 円0. J-Pharma Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 17.83 Mil. Therefore, J-Pharma Co's market cap for the quarter that ended in Dec. 2025 was 円0.00 Mil.
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. J-Pharma Co's Enterprise Value for Today is 円2,840.86 Mil.
J-Pharma Co (TSE:520A) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
J-Pharma Co Market Cap Related Terms
J-Pharma Co Market Cap Historical Data
* Premium members only.
The historical data trend for J-Pharma Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
J-Pharma Co Market Cap Chart
J-Pharma Co Annual Data
Trend
Mar24
Mar25
Market Cap
0.00
0.00
J-Pharma Co Quarterly Data
Mar24
Mar25
Dec25
Market Cap
0.00
0.00
0.00
TSE:520A vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, J-Pharma Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
J-Pharma Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, J-Pharma Co's Market Cap distribution charts can be found below:
* The bar in red indicates where J-Pharma Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
J-Pharma Co's Market Cap for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
J-Pharma Co (TSE:520A) has a Market Cap of 円5,215.55 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on J-Pharma Co and its competitors. According to the industry distribution chart, J-Pharma Co ranks #996 out of 1423 companies in the Biotechnology industry, placing it in the top 70%.
Is J-Pharma Co's Market Cap too high?
J-Pharma Co's current Market Cap is 円5,215.55 Mil. Based on the distribution chart, J-Pharma Co ranks #996 out of 1423 companies in the Biotechnology industry, which is below the industry midpoint. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, J-Pharma Co ranks #996 out of 1423 companies for Market Cap. This places J-Pharma Co in the lower half of its industry. The industry median Market Cap is 115.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 115.88, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on J-Pharma Co and its competitors. For the Biotechnology industry, the median Market Cap is 115.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. J-Pharma Co's current Market Cap is 円5,215.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current Market Cap of 円5,215.55 Mil. The current Market Cap is 円5,215.55 Mil. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current Market Cap is 円5,215.55 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score
Get the complete analysis for TSE:520A
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:520A has been successfully added to your 
